• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • CSAR Subsidiary Regulations: China Consults on the Draft Administrative Measures on Cosmetics Labeling

CSAR Subsidiary Regulations: China Consults on the Draft Administrative Measures on Cosmetics Labeling

Monday, 28 September 2020 / Published in Cosmetics, News, NMPA Registration in China

CSAR Subsidiary Regulations: China Consults on the Draft Administrative Measures on Cosmetics Labeling

Following the release of CSAR (Cosmetic Supervision and Administration Regulation), China has carried out a series of measures to support the cosmetic regulatory framework:

On August 28, 2020, the Department of Cosmetics Regulation under the NMPA (National Medical Products Administration) has entrusted the NIFDC (National Institutes for Food and Drug Control) to release:

  • Regulatory standards for the registration and filing for cosmetic products (Draft)
  • Regulatory standards for the registration and filing for new cosmetic ingredients (Draft)

Some main points incorporated in the new drafts include:

  • The new regulation is intended to standardize cosmetic registration and filing and shift the focus of cosmetic supervision from pre-market to post-market management. 65 articles are contained within 7 chapters:
    • Basic Requirements
    • Format requirements
    • The opening and maintenance of user permissions
    • Requirements for registration and notification dossiers
    • Requirements for modifications
    • Requirements for registration renewal and cancellations
    • Supplementary provisions
  • Dossiers requirements for new cosmetic ingredient registration and notification are the same. Despite this, new low-risk ingredients will be subject to filing management and requirements regarding safety dossiers consistent with high-risk ingredients, meaning some additional tests may be necessary.
    1 Application Form
    2 R&D Report
    3 Preparation Technique
    4 Stability
    5 Quality Control Standards
    6 Safety Assessment
    7 Functional Basis
    8 Technical Requirements
    9 Samples
  • Alternative methods to animal testing data might be accepted under certain conditions in future. The draft suggests that in future, companies may be able to apply for exemption of toxicological test for imported general cosmetics (currently known as “non-special” cosmetics) if the following preconditions are met:
    • The manufacturers must provide the relevant GMP certification issued by the cosmetic regulatory authority of the country or region where they are located.
    • The safety risk assessment results (including detailed test data, laboratory qualification analysis, etc.) must be sufficient to fully confirm the product safety.
    • Notably, these two conditions are not easily satisfied, and enterprises may still face challenges. Please note that this is merely an opinion draft and at this point in time the information regarding animal test exemption is still very vaguely phrased and it remains uncertain if and how this will be implemented.

On September 1, 2020, the NIFDC issued the draft guidelines for cosmetic efficacy claims and solicited public comments.

Until now, there have been no requirements for cosmetic efficacy claims, with the exception for sunscreens and the waterproof function of sunscreens. The CSAR released in June stipulates that cosmetics efficacy claims should have a sufficient scientific basis.

Key points included in the new draft guidelines are:

  • Four evaluation principles may be used to evaluate cosmetic efficacy claims: human trials, consumer tests, laboratory tests, and document literature.

Also mentioned in the guidelines are the evaluation exemption, accepted evaluation methods, evaluation institutions, obligations of institutions and registrants/filers, necessary content in the evaluation report, etc.

On September 16, 2020, the NIFDC launched the second round of public consultation for the amendments of the cosmetic safety technical specifications (2015 edition).

On September 21, 2020, China NMPA released the draft Administrative Measures on Cosmetics Labeling for public consultation. This draft defines the requirements for cosmetic labeling and claims.

  • Chinese labels of imported cosmetics can be directly used or affixed. The content regarding product safety and efficacy on Chinese labels must be consistent with the content of the original labels.
  • Efficacy claims mentioned on cosmetic labels shall be supported by sufficient scientific basis. Only product whose efficacy was validated by human trials can claim “efficacy validated” on their label.
  • The draft describes 13 types of prohibited claims. The NMPA is planning on dynamically maintaining a list of examples of prohibited claims based on the real cosmetic supervision situation.

Should you have any suggestions, you can email us at li@cisema.com before October 18 and we will gladly submit them to the NMPA on your behalf.

Related articles: Long awaited cosmetics regulation now passed

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Cosmetic Supervision and Administration Regulation, cosmetics, CSAR, Efficacy claims, Safety

What you can read next

Updates on the Medical Device Classification Catalogue in China
China drug registration electronic certificates
China drug registration electronic certificates now available
Cisema Webinar Series
Stay Tuned for Cisema Webinar Series 2022

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.